Human Adipose Derived Stem Cells (hADSC Normal)

iXCells Biotechnologies
Product Code: IXC-10HU-001
Product Group: Primary Cells
CodeSizePrice
IXC-10HU-001-0.5M0.5 million cells/vial£671.00
Quantity:
IXC-10HU-001-1M1 million cells/vial£962.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Target Species: Human
Application: Cell Culture
Shipping:
dry ice
Storage:
Liquid nitrogen

Images

1 / 1

Documents

Further Information

Cell System:
Integumentary
Cell Type:
Adipose-Derived Stem Cells
Disease:
Normal
Organ/Tissue:
Adipose
PMID:
33562165; 33375065; 32424320

References

  • PubMed ID: 33562165 Laiva, A. L., O?Brien, F. J., & Keogh, M. B. (2021). SDF-1? Gene-Activated Collagen Scaffold RESTORES pro-angiogenic wound HEALING features in Human Diabetic Adipose-derived stem cells. Biomedicines, 9(2), 160. doi:10.3390/biomedicines9020160 ? Learn More
  • PubMed ID: 33375065 Suku, M., Laiva, A. L., O?Brien, F. J., & Keogh, M. B. (2021). Anti-ageing protein ?-klotho rejuvenates diabetic stem cells for improved gene-activated scaffold based wound healing. Journal of Personalized Medicine, 11(1), 4. doi:10.3390/jpm11010004 ? Learn More
  • Das, R., Curry, E. J., Le, T. T., Awale, G., Liu, Y., Li, S., . . . Nguyen, T. D. (2020). Biodegradable nanofiber bone-tissue scaffold as remotely-controlled and self-powering electrical stimulator. Nano Energy, 76, 105028. doi:10.1016/j.nanoen.2020.105028 ? Learn More
  • PubMed ID: 32424320 Srifa, W., Kosaric, N., Amorin, A., Jadi, O., Park, Y., Mantri, S., . . . Porteus, M. (2020). Cas9-aav6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice. Nature Communications, 11(1). doi:10.1038/s41467-020-16065-3 ? Learn More

Related Products

Product NameProduct CodeSupplier 

Media

Adipose-Derived Stem Cell Growth Medium - 250mLIXC-MD-0003iXCells Biotechnologies Summary Details
Adipocyte Differentiation MediumIXC-MD-0005iXCells Biotechnologies Summary Details
Osteogenic Differentiation MediumIXC-MD-0006iXCells Biotechnologies Summary Details